|
Market Closed -
Bombay S.E.
06:02:26 2026-08-10 EDT
|
5-day change | 1st Jan Change | ||
| 25.96 INR | +4.97% |
|
+4.97% | +33.81% |
| Market Cap | 116M 1.22M 1.05M 987K 900K 1.69M 1.72M 11.61M 4.54M 58.08M 4.57M 4.47M 194M | P/E 2024 |
-128x | P/E 2025 | -53.4x |
|---|---|---|---|---|---|
| Enterprise Value | 116M 1.21M 1.05M 986K 899K 1.69M 1.72M 11.6M 4.53M 58.01M 4.56M 4.46M 193M | EV / Sales 2024 |
38,257,531x | EV / Sales 2025 | - |
| Free-Float |
48.09% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.97% | ||
| 1 week | +4.97% | ||
| Current month | +4.97% | ||
| 1 month | +10.19% | ||
| 3 months | +15.69% | ||
| 6 months | +27.44% | ||
| Current year | +33.81% |
| 1 week | 25.96 | 25.96 | |
| 1 month | 24.73 | 25.96 | |
| Current year | 19.4 | 25.96 | |
| 1 year | 16.77 | 25.96 | |
| 3 years | 3.75 | 25.96 | |
| 5 years | 3.16 | 25.96 | |
| 10 years | 3.16 | 25.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rattan Kapoor
CEO | Chief Executive Officer | - | 2025-10-15 |
| Director of Finance/CFO | - | 2025-10-27 | |
B. V. Harish
COO | Chief Operating Officer | - | 2025-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2021-06-21 | |
| Director/Board Member | - | 2022-04-20 | |
Rattan Kapoor
BRD | Director/Board Member | - | 2025-10-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.97% | +4.97% | +54.80% | +552.26% | 1.48M | ||
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | ||
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | ||
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | ||
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | ||
| -1.32% | -0.21% | +29.07% | +36.81% | 295B | ||
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | ||
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | ||
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | ||
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | ||
| Average | -0.02% | +1.86% | +35.75% | +95.42% | 365.91B | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.22% | +65.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.12 0.01 0.01 0.01 0.01 0.02 0.02 0.11 0.04 0.56 0.04 0.04 1.87 | - |
| Net income | -406K -4.26K -3.69K -3.46K -3.15K -5.93K -6.02K -40.64K -15.89K -203K -15.98K -15.63K -678K | -1.26M -13.21K -11.45K -10.72K -9.78K -18.39K -18.67K -126K -49.3K -631K -49.6K -48.52K -2.1M |
| Net Debt | -9.31M -97.61K -84.57K -79.24K -72.27K -136K -138K -932K -364K -4.66M -366K -359K -15.54M | -137K -1.44K -1.24K -1.17K -1.06K -2K -2.03K -13.71K -5.36K -68.6K -5.39K -5.28K -229K |
Employees
1
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | ₹25.96 | +4.97% | 215,644 |
- Stock Market
- Stocks
- SHAMROIN Stock
Select your edition
All financial news and data tailored to specific country editions
















